Mylan's (MYL) Pharma Unit Receives Final FDA Approval for ANDA for Fluvastatin (Generic Lescol)
Go back to Mylan's (MYL) Pharma Unit Receives Final FDA Approval for ANDA for Fluvastatin (Generic Lescol)| Mylan Inc. (NASDAQ: MYL) | Delayed: 15.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $55.51 | |||
| Open | $10.56 | 52 Week Low | $33.60 | |||
| Day High | $15.86 | P/E | 10.43 | |||
| Day Low | $15.86 | EPS | $1.52 | |||
| Volume | 45,581 | |||||
